Guardant Health reported after the close of the market on Thursday that its first quarter 2019 revenues were up 84 percent year over year. Read More >

Grail said today that it has raised $390 million in a Series D financing round, which included new investors Public Sector Pension Investment Board, Canada Pension Plan Investment Board, and two other undisclosed contributors.... Read More >

A new consortium spearheaded by the New York Genome Center aims to foster and organize genomic COVID-19 research in the New York metropolitan area. With approximately $2.5 million in philanthropy funding to start, the COVID-19 Genomics Rese... Read More >

Genomic epidemiology papers from two independent teams are exploring potential sources of recent SARS-CoV-2 introductions to Chinas Guangdong province and to Connecticut, respectively, revealing some of the complex dynamics of the coronavir... Read More >

In the months since SARS-CoV-2 emerged and began spreading, researchers have been attempting to collect new data to understand the virus and COVID-19 disease it causes. But they have also been digging into sequence and gene expression data... Read More >

Two months into the COVID-19 pandemic, the number of SARS-CoV-2 molecular diagnostic tests across the US remains woefully inadequate. According to the COVID Tracking Project, a volunteer effort to track testing across the country headed by... Read More >

A new study launched by scientists at Hannover Medical School (MHH) in Germany is determined to find out why patients respond differently to COVID-19. With the help of industry partners including Bionano Genomics, Genoox, Rescale, and Amazo... Read More >

South Korean molecular diagnostics firm Seegene announced after the close of the market on Tuesday that the US Food and Drug Administration has granted Emergency Use Authorization for the firms Allplex 2019-nCoV Assay, a real-time RT-PCR te... Read More >

Exact Sciences reported on Tuesday after the close of the market that its preliminary first quarter revenues are expected to rise about 115 percent, despite the negative impact of the COVID-19 pandemic on orders for its Cologuard colorectal... Read More >

Austrian biopharma firm Viravaxx said on Tuesday that it is collaborating with the Medical University of Vienna to create a platform for diagnostic and vaccine research into COVID-19. The collaborators will use a protein microarray comprisi... Read More >